|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01873 VIVA BIOTECH
Nominal 
1.470 -0.040 (-2.649%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 115,500 | 0 | 0 | 0 |
| Property, plant, equip. & others | 1,304,455 | -3.439% | 1,350,917 | 1,501,711 | 1,269,870 | 520,290 |
| Land & other Lease Assets | 292,863 | -3.541% | 303,614 | 435,669 | 454,031 | 216,720 |
| Intangible Assets | 2,522,468 | -2.119% | 2,577,088 | 2,632,480 | 2,687,863 | 2,317,185 |
| Interests in Asso. & JCEs | 46,808 | 10.388% | 42,403 | 0 | 0 | 0 |
| Other Non-current Assets | 1,007,402 | -2.144% | 1,029,472 | 1,412,188 | 1,649,209 | 1,748,341 |
| 5,173,996 | -4.521% | 5,418,994 | 5,982,048 | 6,060,973 | 4,802,536 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Inventories | 272,700 | 5.003% | 259,707 | 326,031 | 231,721 | 164,745 | |
| Trade Receivables | 420,464 | 3.205% | 407,405 | 445,969 | 429,703 | 320,510 | |
| Cash & Bank Balances | 941,581 | -9.142% | 1,036,322 | 678,569 | 800,947 | 2,308,452 | |
| Other Current Assets | 119,924 | -63.380% | 327,484 | 488,238 | 521,414 | 557,837 | |
| Assets Held for Sale | 121,929 | -- | 0 | 0 | 0 | 0 | |
| 1,876,598 | -7.599% | 2,030,918 | 1,938,807 | 1,983,785 | 3,351,544 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||
| Trade Payables | 309,355 | 25.879% | 245,756 | 326,130 | 281,053 | 295,704 | ||
| S-T Debt & Leases | 552,484 | -41.993% | 952,441 | 1,916,180 | 238,744 | 166,965 | ||
| Other Current Liabilities | 264,762 | -21.197% | 335,981 | 430,247 | 406,806 | 273,003 | ||
| Liab asso w/ Assets Held for Sale | 54 | -- | 0 | 0 | 0 | 0 | ||
| 1,126,655 | -26.563% | 1,534,178 | 2,672,557 | 926,603 | 735,672 | |||
| Net Current Assets | 749,943 | 50.973% | 496,740 | (733,750) | 1,057,182 | 2,615,872 | ||
| Total Assets Less Current Liabilities | 5,923,939 | 0.139% | 5,915,734 | 5,248,298 | 7,118,155 | 7,418,408 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||||
| L-T Debt & Leases | 731,567 | -23.056% | 950,776 | 906,760 | 2,415,953 | 2,802,546 | |||
| Other Non-current Liabilities | 1,376,151 | 7.760% | 1,277,046 | 736,824 | 788,846 | 859,031 | |||
| 2,107,718 | -5.391% | 2,227,822 | 1,643,584 | 3,204,799 | 3,661,577 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||||
| Share Capital | 367 | 0.000% | 367 | 326 | 326 | 323 | ||||
| Reserves | 3,802,010 | 3.104% | 3,687,545 | 3,178,190 | 3,444,299 | 3,287,777 | ||||
| Others | 0 | -- | 0 | 426,198 | 468,731 | 468,731 | ||||
| Shareholders' Funds | 3,802,377 | 3.104% | 3,687,912 | 3,604,714 | 3,913,356 | 3,756,831 | ||||
| Non-controlling Interests | 13,844 | -- | 0 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 3,816,221 | 3.479% | 3,687,912 | 3,604,714 | 3,913,356 | 3,756,831 | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Commitments | -- | -- | 166,333 | 326,732 | 491,174 | 267,416 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 30/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 167,294 |
| %Change | -- |
| EPS / (LPS) | RMB 0.080 |
| NBV Per Share (¥) | RMB 1.783 |